Impact of the National Reimbursement Drug List Negotiation Policy on Accessibility of Anticancer Drugs in China: An Interrupted Time Series Study

ObjectiveSince 2016, the Chinese government has been regularly implementing the National Reimbursement Drug List Negotiation (NRDLN) to improve the accessibility of drugs. In the second round of NRDLN in July 2017, 18 anticancer drugs were included. This study analyzed the impact of the NRDLN on the...

Full description

Saved in:
Bibliographic Details
Main Authors: Hong Zhu (Author), Jingmin Zhu (Author), Yingyu Zhou (Author), Linghan Shan (Author), Cui Li (Author), Yu Cui (Author), Zheng Kang (Author), Mingli Jiao (Author), Huan Liu (Author), Lijun Gao (Author), Qunhong Wu (Author), Yanhua Hao (Author)
Format: Book
Published: Frontiers Media S.A., 2022-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available